• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL, INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL, INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71007
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Post Operative Wound Infection (2446)
Date of Event 12/31/2025
Type of Reportable Event Serious Injury
Event or Problem Description
The patient was implanted with a nalu peripheral nerve stimulator system on (b)(6) 2025 to treat foot pain.At the time of the initial system activation the patient reported good healing and receiving 100% pain relief from the system.On (b)(6) 2025 the patient noticed some redness and discomfort at the incision site for the implantable pulse generator (ipg).Patient was evaluated by the primary doctor (not the implanting doctor) and informed an infection may be developing.The primary doctor cleaned the site and prescribed oral antibiotics.After being seen by the primary doctor, the patient then notified the implanting doctor of the possible infection.The implanting doctor advised to remove the system and culture to determine infection type.On (b)(6) 2025 the ipg was removed, however the doctor was uncomfortable removing the leads as they were scarred in close proximity to the tibial nerve.
 
Additional Manufacturer Narrative
The patient is 86 years old and has a history of cancer as well as other underlying health issues, the specifics were not shared.A culture was taken at the time of ipg explant.The explant results were not made available to the firm however the patient reports presence of two types of bacteria (unknown what types).The patient had initially appeared to be healing well and approximately one month after the procedure noticed the first signs of infection.Infection is a known inherent risk of invasive procedures and it is unknown if or how the patient's pre-existing health conditions may have contributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Common Device Name
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
chelsea gutierrez
2320 faraday ave
suite 100
carlsbad, CA 92008-7241
7144010608
MDR Report Key24393123
Report Number3015425075-2025-00361
Device Sequence Number10257863
Product Code GZF
UDI-Device Identifier00812537037356
UDI-Public(01)00812537037356(11)240801(17)270801
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K183579
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 01/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number71007
Device Catalogue Number71007
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/31/2025
Initial Report FDA Received Date02/19/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-